Long-range axonal retrograde transport is a key mechanism for the cellular dissemination of neuroinvasive viruses, such as Borna disease virus (BDV), for which entry and egress sites are usually distant from the nucleus, where viral replication takes place. Although BDV is known to disseminate very efficiently in neurons, both in vivo and in primary cultures, the modalities of its axonal transport are still poorly characterized. In this work, we combined different methodological approaches, such as confocal microscopy and biochemical purification of endosomes, to study BDV retrograde transport. We demonstrate that BDV ribonucleoparticles (composed of the viral genomic RNA, nucleoprotein and phosphoprotein), as well as the matrix protein, are transported towards the nucleus into endocytic carriers. These specialized organelles, called signalling endosomes, are notably used for the retrograde transport of neurotrophins and activated growth factor receptors. Signalling endosomes have a neutral luminal pH and thereby offer protection against degradation during long-range transport. This particularity could allow the viral particles to be delivered intact to the cell body of neurons, avoiding their premature release in the cytoplasm.
INTRODUCTION
Borna disease virus (BDV) is a non-segmented, negativestranded RNA virus belonging to the Bornaviridae family. Its 8.9 kb genome, the smallest of the Mononegavirales order, encodes only six proteins (de la Torre, 1994) : the nucleoprotein (N), the viral polymerase (L) and its cofactor the phosphoprotein (P), the matrix protein (M), the glycoprotein (G) and the non-structural small protein X. The enveloped virion contains the ribonucleoparticle (RNP), composed of the viral genomic RNA encapsidated into BDV N, in interaction with BDV L, P and M proteins. The envelope is composed of a membrane in which the two isoforms of BDV G (84 and 43 kDa) are found (Gonzalez-Dunia et al., 1998) .
In vivo, BDV preferentially targets neurons of the central nervous system (CNS), although it can infect a large variety of cell types in vitro (de la Torre, 2002; Gonzalez-Dunia et al., 2005) . It has the particularity, unique among Mononegavirales, to replicate in the nucleus of infected cells without developing any cytopathic effect. Despite numerous studies, some steps of its replication cycle remain unknown. In particular, receptor-mediated entry, retrograde transport to the nucleus, virion assembly and release are not well characterized (Lipkin et al., 2011) . Following interaction with a still unknown receptor, BDV enters the cell via clathrin-dependent endocytosis to form a vesicle that fuses with an early endosome. Then, acidification of the late endosome allows the fusion between viral and endosomal membranes and RNP release (Clemente & de la Torre, 2009 ). After genome replication and protein synthesis, the precise modalities of virion assembly are still unknown. In particular, whether RNPs follow an anterograde transport route in an enveloped form or naked is not known, and even if neuron-to-neuron transmission occurs with enveloped virions and/or with non-enveloped RNPs (Clemente & de la Torre, 2007) . Previous work from our team allowed the observation of BDV RNP trafficking in non-neuronal cells by the use of a recombinant fluorescent-tagged virus (Charlier et al., 2013) . In neurons, however, one important feature of the BDV replication cycle is the necessity of a long-range retrograde and anterograde transport via the axonal route, since entry and egress sites are often distant from the cell body, where viral replication takes place.
Axonal transport is a key mechanism for neuroinvasive pathogens (Taylor & Enquist, 2015) . Indeed, the long distances separating somas from nerve terminals imply that neurotropic viruses must use specialized molecular motors to move in a vectorial manner along axons and cannot solely rely on passive diffusion. Two principal strategies for axonal retrograde transport are described for pathogens (Salinas et al., 2010) . The first one is to directly recruit molecular motors, such as cytoplasmic dynein or its associated complex dynactin, as exemplified by herpes simplex virus type 1. After membrane fusion, the herpes simplex virus type 1 core and tegument proteins are released into the cytoplasm. Several viral proteins then recruit dynein, dynactin and adaptor proteins, allowing a rapid retrograde transport along microtubules (Diefenbach et al., 2008) . Another strategy for axonal trafficking is to use vesicular transport. Indeed, membrane organelles, such as endocytic and exocytic vesicles, constantly travel along axons and several pathogens access these organelles to spread in the CNS. For example, this is the case for canine adenovirus type 2, which enters the cell by receptor-mediated endocytosis before travelling into axonal endosomes (Salinas et al., 2009) . Another well-documented example is tetanus neurotoxin (TeNT), which also uses the vesicular pathway to be transported in neurons (Lalli et al., 2003) . These endocytic structures, also called signalling endosomes, are usually responsible for the transport of neurotrophins, such as nerve growth factor or brain-derived neurotrophic factor, as well as of their corresponding receptors p75 NTR and TrkB (Bucci et al., 2014) . An important characteristic of these vesicles is that their luminal pH is close to neutral (Bohnert & Schiavo, 2005) . This allows cargoes to be transported over long distances in a protective environment, avoiding pH-dependent conformational changes. Neutral axonal endosomes could therefore constitute an ideal transport pathway for neurotropic viruses to reach the cell body without destabilization of the viral particle, preventing membrane fusion and premature release of the viral genome (Salinas et al., 2010) .
Although BDV is known to disseminate particularly well in neurons, both in vivo in the CNS and in vitro in neuronal primary cultures or in organotypic hippocampal slices (Bajramovic et al., 2003; Daito et al., 2011a; Wu et al., 2013) , the modalities of its axonal transport are still poorly characterized. So far, no study has described any direct interaction between a component of the BDV particle and a molecular motor. Moreover, BDV entry follows a receptor-dependent endocytosis pathway that requires the small GTPase Rab5 (Clemente & de la Torre, 2009 ), a protein also implicated in the transport of axonal endosomes (Deinhardt et al., 2006) . These data argue for the hypothesis that BDV particles could be transported into signalling endosomes. In this work, we combined different methodological approaches, based on colocalization studies and biochemical purification of endosomes, to determine whether BDV uses such vesicular pathways for its retrograde axonal transport.
RESULTS

BDV particles and TeNT colocalize in axonal vesicles
In a first attempt to investigate whether BDV particles are transported along axonal endosomes, we sought to perform colocalization studies between BDV and known axonal cargoes. Among well-described axonal cargoes, TeNT undergoes specific uptake and retrograde transport in axonal endosomes (Lalli & Schiavo, 2002) . Here, we used the binding fragment of TeNT (H C T), coupled to Alexa Fluor 555 (H C T-555), which is a very reliable tool to monitor axonal retrograde transport of signalling endosomes (Debaisieux et al., 2016; Lalli & Schiavo, 2002; Lalli et al., 1999) . Therefore, we performed colocalization studies between H C T-555 and BDV particles in fixed neurons.
To this end, we used primary cultures of hippocampal neurons, which present long axons allowing easy detection of BDV particles. By performing preliminary kinetic analyses of infection, we determined that a punctate staining, probably corresponding to BDV particles, was best detected in axons 8-10 days after virus inoculation (data not shown). We thus labelled neurons with H C T-555 at 10 days postinfection before proceeding to colocalization studies. We performed indirect immunofluorescence experiments against BDV N or P proteins, the two main components of BDV RNPs, and colocalization analyses with H C T-555 were performed by confocal microscopy (Fig. 1a, b , upper panels). In parallel, neurons were stained for b-tubulin III, to verify the axonal integrity (data not shown). Each colocalization event was confirmed by drawing an intensity profile (Fig. 1a, b , lower panels). To determine the colocalization percentages between BDV N or P and H C T-555, we analysed all the vesicles containing BDV N or P proteins. Among them, we determined the proportion that was also positive for H C T-555 (Fig. 1c) . We observed that around 75 % of BDV N-containing vesicles and 65 % of BDV Pcontaining vesicles were also positive for H C T-555. These first results argue for a transport of BDV in axonal endosomes in cultured hippocampal neurons.
Biochemical approaches to purifying axonal endosomes
We next decided to complete these results by a biochemical approach based on the purification of axonal endosomes and the analysis of their protein content (Fig. 2) . Primary cultures of cortical neurons were infected by BDV, or left non-infected as a control, and maintained for 13 days, a time necessary to allow BDV spreading to the entire culture, as demonstrated in previous studies (Bajramovic et al., 2003) . They were then submitted to either whole-cell lysis or gentle cell lysis to preserve cellular organelles, notably axonal endosomes (see Fig. 2 and Methods). We next used two complementary methods to obtain axonal endosome-enriched fractions (Fig. 2) . The first one consisted of performing immunoprecipitation against Trk receptors, which are markers for axonal endosomes (method 1) (Bucci et al., 2014) . The second one consisted of flow cytometry-based sorting of axonal endosomes labelled by fluorescent H C T that was beforehand pre-incubated with neurons (method 2).
Axonal endosomes obtained by immunoprecipitation contain BDV proteins
We first sought to purify axonal endosomes by performing immunoprecipitation experiments using a pan-Trk antibody. This antibody recognizes the cytoplasmic portion of Trk receptors, the cellular receptors of several neurotrophins, including brain-derived neurotrophic factor, which localize in axonal endosomes (Lalli & Schiavo, 2002) . The protein content of the immunoprecipitates was then analysed by Western blotting (Fig. 3) .
We first carried out control experiments in which we performed a whole-cell lysis of non-infected or infected neurons, leading to the disruption of all cellular organelles, including axonal endosomes (Fig. 3 ). As expected, we observed the presence of TrkB in the immunoprecipitates (Fig. 3a) . Another endosomal marker, Rab7 (Chavrier et al., 1990) , which does not interact with Trk receptors, was also detected in the input fractions, but not in the immunoprecipitates, confirming that axonal endosomes had indeed been disrupted during cell lysis. Moreover, BDV N, P, G and M proteins were not found in the immunoprecipitate obtained from infected neurons, indicating that they do not directly interact with Trk receptors (Fig. 3a) .
We repeated the same anti-pan-Trk immunoprecipitation experiment after having performed a gentle cell lysis to preserve axonal endosomes (Fig. 3b) . In this case, Rab7 was found associated to the Trk immunoprecipitates, in contrast to what was observed with whole-cell lysis, indicating that this method allows the preservation of axonal endosome integrity. Moreover, BDV N, P, G and M were also found in the immunoprecipitates obtained from infected neurons, indicating that BDV proteins are present in the axonal endosome-enriched fraction.
However, we reasoned that this purification method based on the isolation of Trk-containing endosomes might not be optimal. Indeed, Trk receptors follow the classical secretory pathway. As such, they transit through the endoplasmic reticulum (ER) and Golgi apparatus after synthesis before reaching the plasma membrane. As a matter of fact, Western blot experiments revealed that markers such as GM130 (Golgi matrix protein of 130 kDa), ERGIC (ER Golgi intermediate compartment) and calnexin (ER) (Marra et al., 2001; Schweizer et al., 1988; Wada et al., 1991) were also present in our immunoprecipitates ( Fig. 3c) , suggesting that the immunoprecipitates of Trk-containing axonal endosomes may also contain other subcellular organelles. 
Flow cytometry-sorted axonal endosomes contain BDV proteins and the viral genome
We thus decided to develop an alternative approach to purifying axonal endosomes with greater efficiency. To this end, we developed a biochemical approach based on flow cytometry sorting of fluorescently labelled endosomes. Similar to our colocalization studies (see Fig. 1 ), we used H C T as an endosomal probe, which was labelled with Alexa Fluor 647 dye for its detection by flow cytometry (H C T-647).
Considering the expected size of axonal endosomes (between 100 nm and 1 µm), we first calibrated our flow cytometer for the detection of small particles. Latex particles of distinct known sizes (0.1, 0.5, 1 and 3 µm) were used to set up the flow cytometer FSC and SSC parameters. We next observed that we could also detect and discriminate fluorescent standard microbeads of 0.5, 0.9 and 3 µm (data not shown). Next, we analysed cell homogenates obtained by gentle cell lysis of non-infected neurons that had been previously incubated with H C T-647. Flow cytometry analysis of the crude cell homogenates revealed a population of events with a relatively continuous size and granulometry distribution (Fig. 4a, left panel) . These events were sizegated into three populations, designated as P1 to P3, that were then analysed for fluorescence intensity and count number (Fig. 4a) . Alexa 647-positive events were then gated and sorted to obtain F1 and F2 fractions. As expected, no fluorescent events were detected in a control experiment using neurons that had not been exposed to H C T-647 (Fig. 4b) .
We next analysed the protein content of the sorted endosome-containing fractions obtained from non-infected or infected neurons. We focused on the F1 fraction because it mostly contains fluorescent events (>86 %). Moreover, the paucity of the material present in F2 fractions (680 fluorescent positive events sorted in F2 fraction versus 2880 in F1 fraction) limited the protein content available for Western blotting experiments. In F1 fractions sorted from non-infected neurons, Western blot analysis revealed the presence of the axonal endosome markers TrkB and Rab7, suggesting that this method allowed the purification of preserved axonal endosomes (Fig. 5a, left panel) . When a similar analysis was performed using infected neurons, we also detected the presence of BDV N, P and M proteins in addition to TrkB and Rab7 (Fig. 5a , right panels). We did not, however, succeed in detecting BDV G isoforms, probably due to the limiting amounts of protein content, together with the fact that anti-BDV G antibody is not as sensitive as the other anti-BDV antibodies used in this study (data not shown). Moreover, in contrast to the results obtained with the immunopurification of Trk-containing endosomes, Western blot analysis of F1-sorted fractions revealed that they were negative for GM130, calnexin or ERGIC antigens (Fig. 5b) , suggesting that such a flow cytometry-based sorting allows a more stringent purification of axonal endosomes.
Lastly, we investigated whether BDV genomic RNA was also found in F1-sorted fractions. We purified total RNAs from F1 fractions and performed a reverse transcription experiment targeting the viral (negative-sense) genomic RNA. The resulting cDNAs were then amplified by PCR, using BDV-specific primers. As shown in Fig. 5(c) , a DNA fragment at the expected size of 360 bp was amplified specifically in F1 fractions obtained from infected neurons, demonstrating that the viral genomic RNA is present in axonal endosomes, in addition to the above-mentioned BDV proteins.
DISCUSSION
One requirement for neurotropic viruses to disseminate efficiently into the CNS is that viral proteins, genome and/ or particle must move over long distances along axons, a highly specialized neuronal compartment. Although the strong neuroinvasive properties of BDV have been observed long ago, either in animal models or using in vitro systems (Bajramovic et al., 2003; Daito et al., 2011a; Wu et al., 2013) , the strategy adopted by this virus upon infection to reach the neuronal nucleus, where viral replication takes place, still remains a mystery. In this study, we sought to gain further insights into the modalities of BDV axonal transport.
Colocalization studies performed by confocal microscopy on hippocampal axons indicated that approximately 70 % of BDV antigen-containing puncta were also positive for H C T, a probe specific for axonal endosomes (Lalli et al., 2003; Salinas et al., 2010) . It should be noted, however, that part of this staining could correspond to isolated viral proteins, since we have been unable to assess the colocalization between H C T and more than one viral element at the time. This result is comparable to what has been observed with canine adenovirus type 2, another virus described to travel in signalling endosomes in motor neurons (Salinas et al., 2009) , and therefore constitutes a strong argument in favour of BDV being recruited to axonal transport carriers. The remaining 30 % of BDV antigen-containing puncta that are negative for H C T could have stochastically internalized BDV and not H C T. It is also possible that part of this staining corresponds to vesicles containing newly synthesized BDV virions (or RNPs) that are travelling in an anterograde direction and thus do not contain H C T. Indeed, even if a punctate axonal staining for BDV antigens is usually observed at early stages after infection, we cannot exclude the possibility that neo-synthetized virions may also be present in neurons, since our immunofluorescence analyses have been performed 10 days post-infection, a time sufficient to allow production of new viral progeny. Indeed, given the paucity of cell-free virus produced by BDVinfected cells, it is unfortunately not possible to use a stronger m.o.i. and visualize viral spread at earlier time points.
We next decided to perform biochemical purification of Trk-containing endosomes, taking advantage of an experimental strategy used by several groups for the study of signalling endosomes (Mitchell et al., 2012; Zhou et al., 2012) . By this method, we were able to detect axonal endosome markers, such as TrkB and Rab7 in the immunoprecipitates, validating this experimental approach. Moreover, BDV N, P, M and G proteins were also found in the immunoprecipitates. However, a key feature of axonal transport is that cellular proteins that will ultimately be transported in a retrograde manner, such as Trk receptors themselves, must first be delivered to the axon terminus.
Consequently, Trk receptors first follow the classical cellular secretory pathway, transiting via ER and Golgi apparatus and reaching the axon terminus by anterograde transport (Ascaño et al., 2009) . Thus, immunoprecipitation of Trk-containing endosomes purifies not only endosomes that move in the retrograde direction but also vesicles that are delivered to the axon plasma membrane, as well as ERand Golgi-derived microsomes. Control Western blot experiments indeed showed that ER and Golgi proteins were present in pan-Trk immunoprecipitates. In any event, as BDV N, P and M are directly translated into the cell cytoplasm and not on ER-associated ribosomes, our results clearly demonstrate that these proteins are found in axonal endosomes. For BDV G, however, results need to be interpreted with caution. Indeed, BDV G follows the cellular secretory pathway and both the entire protein and its two cleaved isoforms associate with ER and Golgi (Daito et al., 2011b) . We therefore cannot rule out the possibility that part of BDV G may actually be immunoprecipitated from ER-and Golgi-derived microsomes.
Flow cytometry-based sorting of H C T-containing vesicles allowed us to definitively conclude that BDV components were actually transported by axonal endosomes. Clearly, H C T represents a more stringent marker of axonal endosomes than Trk receptors, since it only follows retrograde transport and does not transit through the ER or Golgi (Lalli et al., 2003; Salinas et al., 2010) . As a matter of fact, no trace of ER or Golgi apparatus markers were found in the sorted fractions, confirming the reliability of H C T as an axonal endosome probe. This also demonstrates that the use of a cell cracker is indeed appropriate to obtain intact endosomes, since it has been suggested that the mechanical forces applied for cell fractionation might create hybrid membrane vesicles (Salomon et al., 2010) .
Since BDV N, P and M proteins, as well as the viral genome, were all detected in sorted H C T-positive fractions, it is very likely that BDV RNPs are actually present in axonal endosomes. We, however, were unable to detect BDV G by Western blot. We thus cannot conclude whether BDV particles are transported along axonal endosomes in an enveloped or uncoated form. In neuronal primary cultures, BDV spreads without any detectable extracellular virus or syncytium formation (Bajramovic et al., 2003) and the precise contribution of BDV G in neuronal spread remains debated (Clemente & de la Torre, 2007) . One current hypothesis proposes two modes of virus propagation into neurons: a primary infection that depends on the binding of BDV G to its receptor, followed by a cell-to-cell viral spread that would not necessarily require the BDV G protein (Lennartz et al., 2016) . Another common pathway between H C T and BDV is the initial association with Rab5-positive early endosomes. This is particularly interesting when considering that there are clear functional differences between axonal endosomes and endocytic organelles found in epithelial cells. Notably, in contrast to epithelial cells, Rab7-positive axonal endosomes display a neutral luminal pH (Bohnert & Schiavo, 2005; Salinas et al., 2009) . By transiting through such non-acidic axonal endosomes, BDV particles could remain efficiently associated with long-range transport vesicles until being delivered to the soma, triggering the exit of the viral material from these compartments. As such, neutral axonal endosomes may offer efficient protection against degradation during long-range transport, allowing the viral particle to be delivered intact to the cell body of neurons. This might also explain why BDV disseminates much better in primary neuronal cultures when compared to other cell types. In non-neuronal cell types, the cell-to-cell spread of BDV is relatively inefficient, as attested by the paucity of BDV fluorescent particles routing to the nucleus detected in our recent study, which had been performed in epithelial Vero cells (Charlier et al., 2013) . This may actually be explained by the fact that BDV particles would be prematurely released into the cytoplasm, due to the early acidification of endosomes.
Recently, a proteomic analysis of the composition of signalling endosomes revealed that they contain many proteins, notably receptors, which play key roles in infection and spread of many neurotropic viruses (Debaisieux et al., 2016) . Such knowledge may now provide new leads towards the identification of the cellular receptor for BDV, thereby contributing to a better understanding of BDV neuropathogenesis.
METHODS
Ethics statement. Animal handling and care for the preparation of primary neuronal cultures were performed in agreement with the European Union Council Directive 86/609/EEC and experiments were done following the French national chart for ethics of animal experiments (articles R 214-87 to 90 of the 'Code rural'). Our protocol received approval from the local committee on the ethics of animal experiments (permit number: 04-U1043-DG-06). Rats were deeply anaesthetized with CO 2 before euthanasia.
Primary neuronal cultures and virus infection. Before seeding, supports were coated with 500 µg ml À1 poly-L-ornithine (Sigma), followed by 5 µg ml À1 laminin (Roche). Primary cortical neurons were prepared from Sprague-Dawley rat embryos at gestational day 17 by the papain dissociation method as described previously (Bonnaud et al., 2015) . Hippocampal neurons were prepared from newborn SpragueDawley rats as described previously (Prat et al., 2009) . Neurons were maintained in neurobasal medium (Invitrogen) supplemented with 100 µg ml À1 penicillin/streptomycin, 2 mM glutamine, 2 % B-27 supplement (Invitrogen) and 1 % FCS for hippocampal neurons. Neuronal cultures contained more than 90 % neurons, as assessed by staining with the neuron-specific marker b-tubulin III (data not shown).
Neurons were infected 1 day after plating with cell-free BDV. Cellreleased virus stocks were prepared as described using Vero cells persistently infected by wild-type BDV (Giessen strain He/80) (Prat et al., 2009) . Efficient BDV infection of neurons was verified by indirect immunofluorescence for each experiment.
Labelling of axonal endosomes with H C T. To visualize axonal endosomes by confocal microscopy, hippocampal neurons were incubated with the binding fragment of TeNT (H C T) that was coupled with Alexa Fluor 555 dye (H C T-555), as described previously (Lalli & Schiavo, 2002) . Incubation was performed with 10 nM H C T-555 for 1 h at 37 C in neurobasal medium. To eliminate the excess of non-internalized toxin that could remain bound to cell surface receptors, one acid wash was then performed for 1 min on ice with a solution containing 100 mM citric acid and 142 mM NaCl (pH 2), followed by two washes in PBS (Invitrogen).
To perform flow cytometry analysis and sorting, cortical neurons were incubated with H C T coupled with Alexa Fluor 647 dye (H C T-647). Incubation was performed in neurobasal medium containing 20 nM H C T-647, for 3 h at 37 C, followed by a 10 min incubation on ice. One acid wash was then performed followed by two washes with Hanks' buffered salt solution (Invitrogen) supplemented with protease inhibitors.
Indirect immunofluorescence analysis. Neurons were fixed with 2 % paraformaldehyde at room temperature for 10 min then with 4 % paraformaldehyde for 10 min. They were then washed three times with PBS and permeabilized with PBS containing 0.1 % Triton X-100 for 4 min. After two washes with PBS, non-specific antigenic binding sites were blocked with 2.5 % normal goat serum (Invitrogen) for at least 1 h. Rabbit antisera recognising BDV N or P proteins (Bonnaud et al., 2015) were diluted in PBS containing 2.5 % normal goat serum and incubated for 1 h at room temperature. After three washes with PBS (containing 0.1 % Triton X-100 in the first one), neurons were incubated with secondary goat anti-rabbit antibody coupled to Alexa Fluor 488 during 1 h at room temperature. After three washes, coverslips were mounted onto microscope slides using Vectashield mounting medium (Vector Laboratories) containing DAPI. Images were acquired on a LSM 710 confocal microscope (Zeiss) using fixed acquisition parameters and a Â63 objective. ImageJ software was used for colocalization analyses.
Preparation of cell extracts. For whole-cell extract preparation, neurons were washed twice with PBS, scrapped and centrifuged for 5 min at 170 g at 4 C. Cell pellets were suspended in lysis solution containing 500 mM Tris/HCl (pH 8), 150 mM NaCl, 0.1 % SDS, 1 % Nonidet P-40, 0.5 % sodium deoxycholate, 1 mM sodium orthovanadate and protease inhibitors (cOmplete Mini, Roche) and were incubated for 30 min at 4 C. Lysates were then centrifuged at 16 000 g for 20 min at 4 C to eliminate cellular debris.
To preserve endosome integrity before immunoprecipitation, a gentle cell lysis was performed as follows. After two washes with Hanks' buffered salt solution containing protease inhibitors, neurons were scrapped and centrifuged for 5 min at 170 g and 4 C. Cell pellets were resuspended in breaking buffer (BB) containing 10 mM HEPES (pH 7.2), 0.25 M sucrose, 1 mM EDTA, 1 mM magnesium acetate and protease inhibitors. Gentle lysis was achieved by 15 passages through a cell cracker (18 µm clearance; EMBL Technology Transfer). Homogenates were clarified by centrifugation at 690 g for 15 min at 4 C and kept at À80 C for further analyses.
To perform flow cytometry-based sorting, the following lysis buffer was used: 25 mM MES, 150 mM NaCl, 5 mM EDTA and protease inhibitors at pH 6.5 (Chasan et al., 2013) .
Immunoprecipitation experiments. Protein concentrations of the extracts were determined using a Bradford assay. Then, 250 µg was used for all experiments and diluted in a final volume of 500 µl BB. Lysates were precleared for 30 min at 4 C using 50 µl µMACS protein G microbeads (Miltenyi Biotec). In parallel, 2 µg goat anti-pan-Trk antibodies (Santa Cruz Biotechnologies) was coupled with 50 µl µMACS protein G microbeads (Myltenyi Biotec), then washed with BB and passed on a magnetic column (µ Columns; Miltenyi Biotec). After removal from the magnetic field, the precleared lysates were mixed with the coupled microbeads and incubated for 2 h at 4 C. After four washes on the magnetic column, elution of immunoprecipitates was performed by boiling with 60 µl Laemmli buffer.
Flow cytometry analysis and sorting. H c T-647-labelled neuronal extracts obtained after gentle lysis were analysed and sorted by flow cytometry using a BD FACSAria II SORP (BD Biosciences) equipped with DIVA software, using a protocol adapted from Chasan et al. (2013) . Calibration was performed with size-standard latex microbeads of 0.1, 0.5, 1 and 3 µm and 0.5, 0.9 and 3 µm FITC microbeads (Biocytex) and the fluid sheath running through the cytometer was filtered before use. Samples were analysed at a speed of 500-1000 events per second. A minimum of 10 000 events was collected for analysis. Data were analysed using the FlowJo software (Tree Star).
Western blotting. Western blots were performed as previously described (Prat et al., 2009) , by using the following primary antibodies: rabbit sera anti-BDV N, P, M and G (kindly provided by Martin Schwemmle for BDV M and Keizo Tomonaga for BDV G antibodies); rabbit anti-TrkB antibody (Santa Cruz Biotechnology); anti-Rab7 antibody (Cell Signaling Technology); anti-calnexin antibody (Enzo Life Sciences); anti-GM130 antibody (BD Biosciences) and mouse monoclonal anti-ERGIC antibody (Sigma-Aldrich). The secondary antibodies used were anti-rabbit and anti-mouse antibodies coupled to 680 and 770 nm infrared dyes (Biotium). Laser scanning of blots and analyses was performed using the Odyssey Infrared Imaging System (Li-Cor).
Detection of BDV genomic RNA by reverse transcription and PCR. Total RNAs were extracted from input or sorted fractions using the RNeasy micro kit (Qiagen), following the manufacturer's instructions. RNAs were reverse transcribed using SuperScript III Reverse Transcriptase (Life Technologies) with a primer specific for genomic viral RNA (primer sequence: 5¢-GACACTACGACGGGAACGAT-3¢). The resulting cDNAs were then submitted to PCR analysis using BDVspecific primers (forward primer: 5¢-CGGTAGACCAGCTCCTGAAG-3¢, reverse primer: 5¢-GAGGTCCACCTTCTCCATCA-3¢), using Phusion DNA polymerase (Fermentas) and the following cycles: 3 min at 98 C then 30 cycles with 10 s at 98 C, 10 s at 55 C, 15 s at 72 C and a final incubation of 5 min at 72 C.
